Interestingly, in a recent study by Lindskog and collaborators [19], an upregulation of ACE2 was observed in endothelial cells in the brains of patients with COVID-19, most prominently in the white matter and with the highest expression observed in the patients exhibiting the most severe neurological symptoms [19]. The gene discussed is ACE2; the disease is COVID-19.